Based on these findings, this study was initiated to assess whether RvD1 attenuated susceptibility to ischemic AKI in diabetes through inhibiting the NF-κB-mediated inflammatory response and cell apoptosis. This evidence concerns the gene NFKB1 and diabetes mellitus.